Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
Conditions: Squamous Cell Non-small Cell Lung Cancer Interventions: Drug: JMT101; Drug: docetaxel; Drug: HB1801 Sponsors: Shanghai JMT-Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs
Conditions: Lung Cancer; Blood Biomarkers Interventions: Diagnostic Test: Artificial Intelligence risk model Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Milano Bicocca Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
Conditions: Non-small Cell Lung Cancer Interventions: Drug: Botensilimab + Balstilimab Sponsors: Immune Oncology Research Institute; Agenus Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Conditions: Breast Cancer; Lung Cancer; Melanoma; Head and Neck Cancer; Urothelial Carcinoma; Colorectal Cancer; Liver Metastases; Lung Metastases Interventions: Genetic: Cohort A: primarily operable disease, candidate to adjuvant; Genetic: Cohort B: locally advanced disease; Genetic: Cohort C: metastatic disease; Genetic: Cohort D: Progressive disease; Genetic: Cohort E: Hematological neoplasms; Genetic: Cohort F: Toxicity Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Conditions: Lung Cancer Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis
Conditions: NSCLC; Brain Metastases; ROS1 Gene Rearrangement Interventions: Drug: Repotrectinib Sponsors: MedSIR; Medical University of Vienna Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data
Conditions: Lung Cancer Interventions: Other: relaxing eligibility criteria Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Metastatic Lung Carcinoma; Metastatic Malignant Neoplasm in the Brain; Stage IV Lung Cancer AJCC v8 Interventions: Behavioral: Behavioral Dietary Intervention; Other: Text Message-Based Navigation Intervention; Other: Internet-Based Intervention; Behavioral: Dietary Counseling and Surveillance; Radiation: Stereotactic Radiosurgery; Procedure: Biospecimen Collection; Procedure: Magnetic Resonance Imaging; Other: Neurocognitive Assessment; Other: Questionnaire Administration; Other: Interview; Other: Internet-Based Intervention; Radiation: Ster...
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor
Conditions: Non-small Cell Lung Cancer Stage IIIB/IV Interventions: Drug: Navelbine oral,Pembrolizumab Sponsors: Guangzhou Institute of Respiratory Disease Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
Conditions: Non-small Cell Lung Cancer; Older People; Carbon Ion Radiotherapy; Radiotherapy Side Effect Interventions: Radiation: carbon ion radiotherapy; Other: targeted therapy; Other: single regimen chemotherapy in sequence with radiotherapy Sponsors: Jian Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Safety of Effivia ®, a Bevacizumab Biosimilar
Conditions: Metastatic Colorectal Cancer; Metastatic Cervical Cancer; Non Squamous Non Small Cell Lung Cancer Interventions: Drug: Bevacizumab Biosimilar MB02 Sponsors: Laboratorios Liomont; Servicios Especializados en Ensayos Cl ínicos, S.C. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without MK- 2870 in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Conditions: Non Small Cell Lung Cancer Interventions: Biological: MK-2870; Biological: Pembrolizumab; Drug: Cisplatin; Drug: Pemetrexed; Drug: Gemcitabine; Drug: Carboplatin; Drug: Paclitaxel Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Study to Compare ABP 234 and Keytruda ® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Conditions: Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Interventions: Drug: ABP 234; Drug: Pembrolizumab (US); Drug: Pembrolizumab (EU) Sponsors: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy
Conditions: NSCLC Stage IV Interventions: Radiation: SBRT or LDRT; Drug: PD-1/PD-L1 inhibitor combined with platinum-based chemotherapy Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Randomized Controlled Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB
Conditions: Pulmonary Nodule, Solitary; Lung Cancer Interventions: Device: Ion Endoluminal System; Device: superDimension Navigation System and Accessories Sponsors: Intuitive Surgical; Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
